Genetic variation in patent foramen ovale: a case-control genome-wide association study

BackgroundPatent foramen ovale (PFO) is a congenital defect between the atria, resulting in abnormal hemodynamics. We conducted a genome-wide association study (GWAS) to identify common genetic variants associated with PFO.MethodsWe performed a whole genome sequencing in a discovery cohort of 3,227...

Full description

Saved in:
Bibliographic Details
Main Authors: Bosi Dong, Yajiao Li, Fandi Ai, Jia Geng, Ting Tang, Wan Peng, Yusha Tang, Hui Wang, Zixuan Tian, Fengxiao Bu, Lei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1523304/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841543788463390720
author Bosi Dong
Yajiao Li
Fandi Ai
Jia Geng
Ting Tang
Wan Peng
Yusha Tang
Hui Wang
Zixuan Tian
Fengxiao Bu
Lei Chen
author_facet Bosi Dong
Yajiao Li
Fandi Ai
Jia Geng
Ting Tang
Wan Peng
Yusha Tang
Hui Wang
Zixuan Tian
Fengxiao Bu
Lei Chen
author_sort Bosi Dong
collection DOAJ
description BackgroundPatent foramen ovale (PFO) is a congenital defect between the atria, resulting in abnormal hemodynamics. We conducted a genome-wide association study (GWAS) to identify common genetic variants associated with PFO.MethodsWe performed a whole genome sequencing in a discovery cohort of 3,227 unrelated Chinese participants screened for PFO via contrast transthoracic echocardiography (cTTE). Single-nucleotide polymorphisms (SNPs) associated with PFO were further validated by Sanger sequencing and subsequently were evaluated in a validation cohort. Expression quantitative trait loci (eQTL) analysis was conducted using the GTEx database. Single-cell sequencing analyses with pseudotime trajectory modeling were employed to evaluate their expression in human fetal hearts.ResultsThe case-control GWAS of discovery cohort ultimately included 517 cases and 517 demographically matched controls. Of the 7,040,407 variants assessed, we identified rs1227675732 (OR = 2.903; 95% CI, 1.961 to 4.297; p = 3.05 × 10−8), rs62206790 (OR = 2.780; 95% CI, 1.864 to 4.146; p = 2.02 × 10−7), rs879176184 (OR = 2.724; 95% CI, 1.822 to 4.073; p = 4.30 × 10−7) and rs13115019 (OR = 2.437; 95% CI, 1.702 to 3.488; p = 5.80 × 10−7) as high-risk variants for PFO, while rs57922961 (OR = 0.5081; 95% CI, 0.388 to 0.666; p = 6.82 × 10−7) was identified as protective variant. These variations were replicated in the validation cohort (111 cases and 152 controls). Single-cell sequencing showed that CNOT2, KCNMB4, MLLT10, IGBP1, and FRG1 were highly expressed with significant changes during heart development.ConclusionThe identification of susceptible loci for PFO might provide insights into the pathogenesis of PFO and contribute to understanding heart development.Clinical Trial Registrationhttps://www.chictr.org.cn/showproj.html?proj=40590, identifier ChiCTR1900024623.
format Article
id doaj-art-c4df83b20ba2450ca9e50e07a857bcec
institution Kabale University
issn 1664-8021
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-c4df83b20ba2450ca9e50e07a857bcec2025-01-13T06:10:58ZengFrontiers Media S.A.Frontiers in Genetics1664-80212025-01-011510.3389/fgene.2024.15233041523304Genetic variation in patent foramen ovale: a case-control genome-wide association studyBosi Dong0Yajiao Li1Fandi Ai2Jia Geng3Ting Tang4Wan Peng5Yusha Tang6Hui Wang7Zixuan Tian8Fengxiao Bu9Lei Chen10Department of Neurology, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, ChinaInstitute of Rare Diseases, West China Hospital of Sichuan University, Chengdu, ChinaInstitute of Rare Diseases, West China Hospital of Sichuan University, Chengdu, ChinaInstitute of Rare Diseases, West China Hospital of Sichuan University, Chengdu, ChinaInstitute of Rare Diseases, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, ChinaInstitute of Rare Diseases, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, ChinaBackgroundPatent foramen ovale (PFO) is a congenital defect between the atria, resulting in abnormal hemodynamics. We conducted a genome-wide association study (GWAS) to identify common genetic variants associated with PFO.MethodsWe performed a whole genome sequencing in a discovery cohort of 3,227 unrelated Chinese participants screened for PFO via contrast transthoracic echocardiography (cTTE). Single-nucleotide polymorphisms (SNPs) associated with PFO were further validated by Sanger sequencing and subsequently were evaluated in a validation cohort. Expression quantitative trait loci (eQTL) analysis was conducted using the GTEx database. Single-cell sequencing analyses with pseudotime trajectory modeling were employed to evaluate their expression in human fetal hearts.ResultsThe case-control GWAS of discovery cohort ultimately included 517 cases and 517 demographically matched controls. Of the 7,040,407 variants assessed, we identified rs1227675732 (OR = 2.903; 95% CI, 1.961 to 4.297; p = 3.05 × 10−8), rs62206790 (OR = 2.780; 95% CI, 1.864 to 4.146; p = 2.02 × 10−7), rs879176184 (OR = 2.724; 95% CI, 1.822 to 4.073; p = 4.30 × 10−7) and rs13115019 (OR = 2.437; 95% CI, 1.702 to 3.488; p = 5.80 × 10−7) as high-risk variants for PFO, while rs57922961 (OR = 0.5081; 95% CI, 0.388 to 0.666; p = 6.82 × 10−7) was identified as protective variant. These variations were replicated in the validation cohort (111 cases and 152 controls). Single-cell sequencing showed that CNOT2, KCNMB4, MLLT10, IGBP1, and FRG1 were highly expressed with significant changes during heart development.ConclusionThe identification of susceptible loci for PFO might provide insights into the pathogenesis of PFO and contribute to understanding heart development.Clinical Trial Registrationhttps://www.chictr.org.cn/showproj.html?proj=40590, identifier ChiCTR1900024623.https://www.frontiersin.org/articles/10.3389/fgene.2024.1523304/fullpatent foramen ovalegenome-wide association studyheart developmentcommon variantssingle-cell sequencing
spellingShingle Bosi Dong
Yajiao Li
Fandi Ai
Jia Geng
Ting Tang
Wan Peng
Yusha Tang
Hui Wang
Zixuan Tian
Fengxiao Bu
Lei Chen
Genetic variation in patent foramen ovale: a case-control genome-wide association study
Frontiers in Genetics
patent foramen ovale
genome-wide association study
heart development
common variants
single-cell sequencing
title Genetic variation in patent foramen ovale: a case-control genome-wide association study
title_full Genetic variation in patent foramen ovale: a case-control genome-wide association study
title_fullStr Genetic variation in patent foramen ovale: a case-control genome-wide association study
title_full_unstemmed Genetic variation in patent foramen ovale: a case-control genome-wide association study
title_short Genetic variation in patent foramen ovale: a case-control genome-wide association study
title_sort genetic variation in patent foramen ovale a case control genome wide association study
topic patent foramen ovale
genome-wide association study
heart development
common variants
single-cell sequencing
url https://www.frontiersin.org/articles/10.3389/fgene.2024.1523304/full
work_keys_str_mv AT bosidong geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT yajiaoli geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT fandiai geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT jiageng geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT tingtang geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT wanpeng geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT yushatang geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT huiwang geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT zixuantian geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT fengxiaobu geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy
AT leichen geneticvariationinpatentforamenovaleacasecontrolgenomewideassociationstudy